TA
TLS Advisors Portfolio holdings
AUM
$32M
This Quarter Return
-6.43%
1 Year Return
+15.09%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$43.7M
AUM Growth
+$43.7M
(-7.6%)
Cap. Flow
-$337K
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
94.53%
Holding
20
New
1
Increased
3
Reduced
3
Closed
3
Top Buys
| 1 |
Valaris
VAL
|
$1.24M |
| 2 |
BHP
BHP
|
$977K |
| 3 |
Vale
VALE
|
$887K |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
$324K |
Top Sells
| 1 |
EQT Corp
EQT
|
$2.19M |
| 2 |
Nucor
NUE
|
$1.2M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$272K |
| 4 |
Ovid Therapeutics
OVID
|
$84.6K |
| 5 |
Xoma
XOMA
|
$18.4K |
Sector Composition
| 1 | Materials | 45.55% |
| 2 | Energy | 22.67% |
| 3 | Communication Services | 14.18% |
| 4 | Healthcare | 13.63% |
| 5 | Consumer Discretionary | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BHP
BHP
$142B
| $8.59M | 19.64% |
175,960
+20,000
| +13% | +$977K |
|
|
2
EQT Corp
EQT
$32.4B
| $6.95M | 15.9% |
150,800
-47,400
| -24% | -$2.19M |
|
3
Meta Platforms (Facebook)
META
$1.86T
| $6.2M | 14.18% |
10,589
| – | – |
|
4
Rio Tinto
RIO
$102B
| $6.06M | 13.86% |
103,100
| – | – |
|
|
5
Vale
VALE
$43.9B
| $5.27M | 12.05% |
594,000
+100,000
| +20% | +$887K |
|
|
6
Xoma
XOMA
$392M
| $3.13M | 7.15% |
119,044
-700
| -0.6% | -$18.4K |
|
7
Range Resources
RRC
$8.16B
| $1.72M | 3.94% |
47,923
| – | – |
|
8
Xenon Pharmaceuticals
XENE
$2.98B
| $1.29M | 2.95% |
32,956
| – | – |
|
|
9
Valaris
VAL
$3.54B
| $1.24M | 2.83% |
+28,000
| New | +$1.24M |
|
10
OmniAb
OABI
$230M
| $886K | 2.03% |
250,185
| – | – |
|
|
11
Ovid Therapeutics
OVID
$91M
| $636K | 1.45% |
680,967
-90,564
| -12% | -$84.6K |
|
12
Hovnanian Enterprises
HOV
$827M
| $518K | 1.18% |
3,872
| – | – |
|
|
13
Materials Select Sector SPDR Fund
XLB
$5.53B
| $501K | 1.15% |
5,950
+3,850
| +183% | +$324K |
|
14
Weyerhaeuser
WY
$18.7B
| $422K | 0.96% |
15,000
| – | – |
|
15
iShares MSCI Singapore ETF
EWS
$792M
| $297K | 0.68% |
13,600
| – | – |
|
|
ENZ
16
DELISTED
Enzo Biochem, Inc.
ENZ
| $10K | 0.02% |
13,616
| – | – |
|
17
Retractable Technologies
RVP
$25.1M
| $8K | 0.02% |
12,152
| – | – |
|
|
18
Nucor
NUE
$34.1B
| – | – |
-8,000
| Closed | -$1.2M |
|
|
19
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – |
-259
| Closed | -$272K |
|
|
NBIS
20
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| – | – |
-17,811
| Closed | – |
|